Roche’s New Nano SmartView Meter Doesn’t Need Coding


By: Diabetes Health Staff

The FDA has given Roche the go-ahead to market its Accu-Chek® Nano SmartView blood glucose monitoring system. The Nano, which uses Accu-Chek SmartView test strips, will be available to US consumers within the first half of this year. It is part of the same product line as the Accu-Chek Aviva Nano and Accu-Chek Performa Nano systems, which Roche has already launched in several overseas markets.

The meter, which Roche describes as smaller than a credit card, does not require coding or calibration. Other features include a large backlit display, customizable test reminders, pre- and post-meal markers, and average glucose calculations. According to Marc Gibeley, head of Roche Diabetes Care North America, “It is easy to use and will help people with diabetes regularly check their blood glucose levels before making informed therapy and lifestyle adjustments.”



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.